Header Logo

Connection

DANIEL D KARP to Topotecan

Back to Details
This is a "connection" page, showing publications DANIEL D KARP has written about Topotecan.
DANIEL D KARP
Connection Strength
0.044
Topotecan
  1. Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study. Invest New Drugs. 2021 10; 39(5):1357-1365.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.